Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

REGENCY CENTERS CORP (REG) Stock Forecast 2025 - AI Price Prediction & Analysis

REGENCY CENTERS CORP (REG) AI Stock Price Forecast & Investment Analysis

REGENCY CENTERS CORP Stock Price Chart and Technical Analysis

Loading REGENCY CENTERS CORP interactive price chart and technical analysis...

REGENCY CENTERS CORP (REG) - Comprehensive Stock Analysis & Investment Research

Deep dive into REGENCY CENTERS CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about REGENCY CENTERS CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For REGENCY CENTERS CORP: REGENCY CENTERS CORP operates in the Real Estate & Construction sector, positioning it as a large-cap market leader.

REGENCY CENTERS CORP (Stock Symbol: REG) is a leading company in the Real Estate & Construction sector , specifically operating within the Real Estate Investment Trusts industry.

The organization employs approximately 1690 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing REGENCY CENTERS CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For REGENCY CENTERS CORP: With $761M in annual revenue and 28.0% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $761 million generating a 28.0% net profit margin .

Market Capitalization: $13188 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 7.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for REGENCY CENTERS CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For REGENCY CENTERS CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for REGENCY CENTERS CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: REGENCY CENTERS CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For REGENCY CENTERS CORP: Strong free cash flow generation demonstrates solid operational efficiency.

REGENCY CENTERS CORP strategically competes in the highly dynamic Real Estate Investment Trusts marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $663 million annually, complemented by impressive -19.7% year-over-year cash flow growth.

The company maintains a healthy 72.5% gross margin, indicating strong pricing power and operational efficiency.

REGENCY CENTERS CORP (REG) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for REGENCY CENTERS CORP stock analysis.

Loading REGENCY CENTERS CORP comprehensive fundamental analysis and insider trading data...

Deep dive into REGENCY CENTERS CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if REGENCY CENTERS CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For REGENCY CENTERS CORP: With a P/E ratio of 61.03, the market highly values future growth prospects.

P/E Ratio 61.03x
P/B Ratio 1.98x
Market Cap $13188M
Dividend Yield 1.95%
EPS $2.78
Book Value/Share $36.78
Revenue/Share $4.20
FCF/Share $3.11
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently REGENCY CENTERS CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For REGENCY CENTERS CORP: An ROE of 7.9% indicates room for improvement in shareholder value creation.

ROE 7.9%
ROA 4.4%
ROIC 5.7%
Gross Margin 72.5%
Operating Margin 40.2%
Net Margin 28.0%
EBT Margin 40.3%
Tax Rate 96.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess REGENCY CENTERS CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For REGENCY CENTERS CORP: A current ratio of 1.20 shows adequate liquidity.

Current Ratio 1.20x
Quick Ratio 1.18x
D/E Ratio 0.64x
Financial Leverage 1.77x
Interest Coverage 4.3x
Working Capital $254M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal REGENCY CENTERS CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For REGENCY CENTERS CORP: Free cash flow of $663M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $663M
Free Cash Flow $663M
Capital Spending $-153M
OCF Growth YoY -19.7%
FCF Growth YoY -19.7%
FCF/Sales 55.5%
CapEx/Sales 30.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively REGENCY CENTERS CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For REGENCY CENTERS CORP: An asset turnover of 0.11x suggests room for improvement in asset utilization.

Asset Turnover 0.11x
Receivables Turnover 10.1x
Fixed Assets Turnover 4.1x
Days Sales Outstanding 36 days
Payables Period 313 days
Understanding Financial Statement Data

What these metrics mean: Key figures from REGENCY CENTERS CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For REGENCY CENTERS CORP: With annual revenue of $761M, REGENCY CENTERS CORP demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $761M
R&D Expense $758M
SG&A Expense $6M
Cost of Goods Sold $27M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 3%
Cash & Short-term Investments 2%
Total Liabilities 43%
Short-term Debt 4%
Accounts Receivable 1%
Inventory 0%
Dividend & Shareholder Information
Dividends Per Share $1.41
Payout Ratio 87.8%
Shares Outstanding 182M

Latest REGENCY CENTERS CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting REGENCY CENTERS CORP (REG) stock price and investment outlook.

📰 We are currently updating our news feed for REGENCY CENTERS CORP. Check back soon for the latest market analysis and company updates.

REGENCY CENTERS CORP Competitors & Peer Analysis - Real Estate & Construction Sector

Comparative analysis of REGENCY CENTERS CORP against industry peers and competitors in the Real Estate & Construction sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAT Unlock Forecast - 30 Days FREE Trial $1220M 13.0x 1.0x
ABR Unlock Forecast - 30 Days FREE Trial $2273M 10.5x 0.8x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3500M 16.4x 1.2x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3461M 16.2x 1.2x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4356M 20.4x 1.5x
ACR Unlock Forecast - 30 Days FREE Trial $137M 6.3x 0.3x
ACRE Unlock Forecast - 30 Days FREE Trial $255M 8.5x 0.5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $178M 8.2x 0.4x
ACR-PD Unlock Forecast - 30 Days FREE Trial $155M 7.2x 0.4x
ADC Unlock Forecast - 30 Days FREE Trial $8537M 44.4x 1.5x
ADC-PA Unlock Forecast - 30 Days FREE Trial $1981M 10.7x 0.4x
AGNC Unlock Forecast - 30 Days FREE Trial $10511M 27.8x 1.0x
AGNCL Unlock Forecast - 30 Days FREE Trial $25720M 68.0x 2.5x
AGNCM Unlock Forecast - 30 Days FREE Trial $25584M 67.7x 2.5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26490M 70.1x 2.6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26220M 69.4x 2.5x
AGNCP Unlock Forecast - 30 Days FREE Trial $25834M 68.3x 2.5x
AHR Unlock Forecast - 30 Days FREE Trial $7059M x 2.9x
AHT Unlock Forecast - 30 Days FREE Trial $29M -1.5x -0.1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $112M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $92M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $84M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $83M x x
AIV Unlock Forecast - 30 Days FREE Trial $787M -6.0x 8.6x
AKR Unlock Forecast - 30 Days FREE Trial $2606M 470.2x 1.2x
ALEX Unlock Forecast - 30 Days FREE Trial $1238M 15.9x 1.2x
ALX Unlock Forecast - 30 Days FREE Trial $1198M 32.0x 8.2x
AMT Unlock Forecast - 30 Days FREE Trial $89084M 68.9x 24.0x
APLE Unlock Forecast - 30 Days FREE Trial $2766M 15.3x 0.9x
ARE Unlock Forecast - 30 Days FREE Trial $13100M 55.8x 0.8x
ARI Unlock Forecast - 30 Days FREE Trial $1428M -9.0x 0.8x
ARR Unlock Forecast - 30 Days FREE Trial $1836M 27.6x 0.9x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1887M x 1.1x
AVB Unlock Forecast - 30 Days FREE Trial $26820M 23.4x 2.3x
BDN Unlock Forecast - 30 Days FREE Trial $643M -5.2x 0.7x
BFS Unlock Forecast - 30 Days FREE Trial $761M 17.7x 2.4x
BFS-PD Unlock Forecast - 30 Days FREE Trial $545M 12.7x 1.7x
BFS-PE Unlock Forecast - 30 Days FREE Trial $564M 13.1x 1.8x
BHM Unlock Forecast - 30 Days FREE Trial $41M 15.0x 0.3x
BHR Unlock Forecast - 30 Days FREE Trial $192M -3.1x 0.9x
BHR-PB Unlock Forecast - 30 Days FREE Trial $1056M x 4.7x
BHR-PD Unlock Forecast - 30 Days FREE Trial $1385M x 6.2x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0.6x
BNL Unlock Forecast - 30 Days FREE Trial $3541M 35.8x 1.2x
BRSP Unlock Forecast - 30 Days FREE Trial $674M -6.6x 0.7x
BRT Unlock Forecast - 30 Days FREE Trial $268M -37.6x 1.4x
BRX Unlock Forecast - 30 Days FREE Trial $8559M 25.5x 2.9x
BXMT Unlock Forecast - 30 Days FREE Trial $3150M -17.4x 0.9x
BXP Unlock Forecast - 30 Days FREE Trial $11676M 2366.0x 2.2x
CBL Unlock Forecast - 30 Days FREE Trial $904M 13.8x 3.1x
CCI Unlock Forecast - 30 Days FREE Trial $42447M 36.6x 6.0x
CDP Unlock Forecast - 30 Days FREE Trial $3204M 21.2x 2.1x
CDR-PB Unlock Forecast - 30 Days FREE Trial $254M 46.0x 11.3x
CDR-PC Unlock Forecast - 30 Days FREE Trial $228M 41.3x 10.2x
CHCT Unlock Forecast - 30 Days FREE Trial $414M -220.9x 0.9x
CHMI Unlock Forecast - 30 Days FREE Trial $87M -9.3x 0.4x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $800M x 3.5x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $859M x 3.7x
CHTH Unlock Forecast - 30 Days FREE Trial $657M x 0.9x
CIM Unlock Forecast - 30 Days FREE Trial $1055M 5.5x 0.4x
CIMN Unlock Forecast - 30 Days FREE Trial $2054M 10.7x 0.8x
CIMO Unlock Forecast - 30 Days FREE Trial $2080M 10.8x 0.8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1783M 9.3x 0.7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $1954M 10.1x 0.7x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1821M 9.5x 0.7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1941M 10.1x 0.7x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15.4x 0.5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1006M x 1.6x
CLDT Unlock Forecast - 30 Days FREE Trial $321M 33.9x 0.4x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1027M 108.6x 1.4x
CMCT Unlock Forecast - 30 Days FREE Trial $5M -0.1x 0.0x
CMRF Unlock Forecast - 30 Days FREE Trial $1026M x 0.6x
COLD Unlock Forecast - 30 Days FREE Trial $3904M -26.5x 1.3x
CPT Unlock Forecast - 30 Days FREE Trial $11231M 72.1x 2.5x
CSR Unlock Forecast - 30 Days FREE Trial $999M -74.6x 1.4x
CTO Unlock Forecast - 30 Days FREE Trial $529M 41.8x 0.9x
CTO-PA Unlock Forecast - 30 Days FREE Trial $687M x 1.2x
CTRE Unlock Forecast - 30 Days FREE Trial $7025M 31.9x 2.1x
CUBE Unlock Forecast - 30 Days FREE Trial $9591M 25.7x 3.4x
CUZ Unlock Forecast - 30 Days FREE Trial $4491M 74.6x 0.9x
CXW Unlock Forecast - 30 Days FREE Trial $2015M 19.4x 1.4x
DEI Unlock Forecast - 30 Days FREE Trial $2235M 59.3x 1.1x
DHC Unlock Forecast - 30 Days FREE Trial $1038M -1.7x 0.6x
DHCNI Unlock Forecast - 30 Days FREE Trial $4056M -10.4x 2.2x
DLR Unlock Forecast - 30 Days FREE Trial $60921M 43.2x 2.7x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $7713M 5.6x 0.3x
DLR-PK Unlock Forecast - 30 Days FREE Trial $8327M 6.0x 0.4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $7536M 5.5x 0.3x
DOC Unlock Forecast - 30 Days FREE Trial $13037M 78.3x 1.7x
DRH Unlock Forecast - 30 Days FREE Trial $1602M 23.6x 1.0x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5206M 76.7x 3.3x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1680M 25.7x 2.9x
DX-PC Unlock Forecast - 30 Days FREE Trial $3201M 48.9x 5.5x
EARN Unlock Forecast - 30 Days FREE Trial $193M -11.6x 0.8x
EGP Unlock Forecast - 30 Days FREE Trial $9453M 38.5x 2.7x
ELME Unlock Forecast - 30 Days FREE Trial $1468M -114.5x 1.6x
ELS Unlock Forecast - 30 Days FREE Trial $11769M 23.6x 6.8x
EPR Unlock Forecast - 30 Days FREE Trial $4110M 22.9x 2.0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $1847M 10.3x 0.9x
EPR-PE Unlock Forecast - 30 Days FREE Trial $2358M 13.1x 1.1x
EPR-PG Unlock Forecast - 30 Days FREE Trial $1587M 8.8x 0.8x
EPRT Unlock Forecast - 30 Days FREE Trial $6170M 25.7x 1.6x
EQIX Unlock Forecast - 30 Days FREE Trial $83057M 81.9x 5.9x
EQR Unlock Forecast - 30 Days FREE Trial $24098M 28.0x 2.2x
ESBA Unlock Forecast - 30 Days FREE Trial $2139M 46.6x x
ESRT Unlock Forecast - 30 Days FREE Trial $2150M 83.1x 2.1x
ESS Unlock Forecast - 30 Days FREE Trial $17045M 21.3x 3.0x
EXR Unlock Forecast - 30 Days FREE Trial $31738M 32.9x 2.3x
FBRT Unlock Forecast - 30 Days FREE Trial $898M 8.2x 0.6x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1838M 16.8x 1.2x
FCPT Unlock Forecast - 30 Days FREE Trial $2502M 23.6x 1.7x
FPI Unlock Forecast - 30 Days FREE Trial $454M 6.5x 453645.3x
FR Unlock Forecast - 30 Days FREE Trial $7429M 31.3x 2.8x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0.0x 0.0x
FRT Unlock Forecast - 30 Days FREE Trial $8738M 25.4x 2.7x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1820M 5.3x 0.6x
FSP Unlock Forecast - 30 Days FREE Trial $143M -1.9x 0.2x
FVR Unlock Forecast - 30 Days FREE Trial $291M x 0.8x
GIPR Unlock Forecast - 30 Days FREE Trial $7M -0.8x 17.0x
GLPI Unlock Forecast - 30 Days FREE Trial $12682M 17.7x 2.8x
GMRE Unlock Forecast - 30 Days FREE Trial $2150M 209.0x 4.3x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1671M 162.4x 3.3x
GNL Unlock Forecast - 30 Days FREE Trial $1701M -4.5x 0.9x
GPMT Unlock Forecast - 30 Days FREE Trial $122M -0.9x 0.2x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $953M x 1.6x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2684M x 3.1x
HHH Unlock Forecast - 30 Days FREE Trial $4849M 68.5x 1.3x
HIW Unlock Forecast - 30 Days FREE Trial $3207M 24.4x 1.4x
HST Unlock Forecast - 30 Days FREE Trial $11392M 17.3x 1.7x
ICRP Unlock Forecast - 30 Days FREE Trial $85M 7.5x 0.4x
ICR-PA Unlock Forecast - 30 Days FREE Trial $197M 17.4x 0.8x
IHT Unlock Forecast - 30 Days FREE Trial $12M -57.7x 3.2x
ILPT Unlock Forecast - 30 Days FREE Trial $399M -2.3x 0.8x
IMPM Unlock Forecast - 30 Days FREE Trial $4M x x
INN Unlock Forecast - 30 Days FREE Trial $585M 68.0x 0.7x
INN-PE Unlock Forecast - 30 Days FREE Trial $2080M 241.6x 2.3x
INN-PF Unlock Forecast - 30 Days FREE Trial $3180M 369.2x 3.6x
IOR Unlock Forecast - 30 Days FREE Trial $72M 16.8x 0.6x
IRM Unlock Forecast - 30 Days FREE Trial $31435M 202.7x -41.7x
IRT Unlock Forecast - 30 Days FREE Trial $3802M 137.0x 1.1x
IVR Unlock Forecast - 30 Days FREE Trial $479M 11.8x 0.7x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1627M 40.1x 2.3x
IVT Unlock Forecast - 30 Days FREE Trial $2242M 20.0x 1.2x
JBGS Unlock Forecast - 30 Days FREE Trial $1332M -11.3x 0.7x
KBSR Unlock Forecast - 30 Days FREE Trial $45M x 0.2x
KIM Unlock Forecast - 30 Days FREE Trial $15129M 25.3x 1.4x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14248M 23.8x 1.4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $14648M 24.5x 1.4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $39332M 65.8x 3.7x
KRC Unlock Forecast - 30 Days FREE Trial $4837M 22.1x 0.9x
KREF Unlock Forecast - 30 Days FREE Trial $562M 952.5x 0.5x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1412M x 1.1x
KRG Unlock Forecast - 30 Days FREE Trial $5045M 27.0x 1.5x
LADR Unlock Forecast - 30 Days FREE Trial $1390M 15.1x 0.9x
LAMR Unlock Forecast - 30 Days FREE Trial $12541M 28.5x 13.9x
LFT Unlock Forecast - 30 Days FREE Trial $93M 6.5x 0.4x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1061M 74.5x 4.6x
LINE Unlock Forecast - 30 Days FREE Trial $9304M x 1.1x
LOAN Unlock Forecast - 30 Days FREE Trial $60M 10.9x 1.4x
LTC Unlock Forecast - 30 Days FREE Trial $1628M 19.6x 1.7x
LXP Unlock Forecast - 30 Days FREE Trial $2824M 32.3x 1.4x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14199M 162.3x 6.9x
MAA Unlock Forecast - 30 Days FREE Trial $15738M 27.5x 2.7x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6515M 11.4x 1.1x
MAC Unlock Forecast - 30 Days FREE Trial $4563M -64.7x 1.8x
MDV Unlock Forecast - 30 Days FREE Trial $170M -24.6x 1.0x
MDV-PA Unlock Forecast - 30 Days FREE Trial $290M x 1.8x
MFA Unlock Forecast - 30 Days FREE Trial $937M 7.3x 0.5x
MFAN Unlock Forecast - 30 Days FREE Trial $2597M 20.2x 1.4x
MFAO Unlock Forecast - 30 Days FREE Trial $2616M 20.4x 1.4x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2132M 16.6x 1.2x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2455M 19.1x 1.4x
MITN Unlock Forecast - 30 Days FREE Trial $755M 16.3x 1.4x
MITP Unlock Forecast - 30 Days FREE Trial $755M 16.3x 1.4x
MITT Unlock Forecast - 30 Days FREE Trial $217M 4.7x 0.4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $666M 14.4x 1.2x
MITT-PB Unlock Forecast - 30 Days FREE Trial $631M 13.6x 1.2x
MITT-PC Unlock Forecast - 30 Days FREE Trial $747M 16.1x 1.4x
MKZR Unlock Forecast - 30 Days FREE Trial $84M x 1.3x
MPW Unlock Forecast - 30 Days FREE Trial $3082M -1.3x 0.6x
NHI Unlock Forecast - 30 Days FREE Trial $3434M 24.0x 2.3x
NLCP Unlock Forecast - 30 Days FREE Trial $270M 10.4x 0.7x
NLOP Unlock Forecast - 30 Days FREE Trial $436M x 0.9x
NLY Unlock Forecast - 30 Days FREE Trial $13452M -22.9x 1.0x
NNN Unlock Forecast - 30 Days FREE Trial $7933M 20.3x 1.8x
NREF Unlock Forecast - 30 Days FREE Trial $243M 2.8x 1.8x
NREF-PA Unlock Forecast - 30 Days FREE Trial $418M 4.8x 3.1x
NSA Unlock Forecast - 30 Days FREE Trial $2416M 26.1x 2.4x
NTST Unlock Forecast - 30 Days FREE Trial $1608M 1247.7x 1.2x
NXDT Unlock Forecast - 30 Days FREE Trial $170M -1.9x 0.2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $672M x 0.9x
NXRT Unlock Forecast - 30 Days FREE Trial $798M 16.6x 2.3x
O Unlock Forecast - 30 Days FREE Trial $55090M 60.1x 1.4x
ONL Unlock Forecast - 30 Days FREE Trial $143M -2.5x 0.2x
ORC Unlock Forecast - 30 Days FREE Trial $949M 148.1x 1.0x
OUT Unlock Forecast - 30 Days FREE Trial $3007M 27.8x 5.6x
PCH Unlock Forecast - 30 Days FREE Trial $3288M 78.9x 1.7x
PCOK Unlock Forecast - 30 Days FREE Trial $5M x 0.2x
PEB Unlock Forecast - 30 Days FREE Trial $1300M -21.5x 0.5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2258M x 0.9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2292M x 0.9x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2323M x 0.9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2066M x 0.8x
PECO Unlock Forecast - 30 Days FREE Trial $4357M 53.2x 1.9x
PGRE Unlock Forecast - 30 Days FREE Trial $1436M -5.8x 0.5x
PINE Unlock Forecast - 30 Days FREE Trial $196M 169.3x 0.9x
PKST Unlock Forecast - 30 Days FREE Trial $525M -3.7x 0.7x
PLD Unlock Forecast - 30 Days FREE Trial $117824M 33.8x 2.2x
PLDGP Unlock Forecast - 30 Days FREE Trial $51710M 15.0x 1.0x
PMT Unlock Forecast - 30 Days FREE Trial $1097M 10.4x 0.6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2073M 19.7x 1.1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2078M 19.8x 1.1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1640M 15.6x 0.9x
PMTU Unlock Forecast - 30 Days FREE Trial $2228M 21.2x 1.2x
PMTV Unlock Forecast - 30 Days FREE Trial $2229M 21.2x 1.2x
PMTW Unlock Forecast - 30 Days FREE Trial $2222M 21.1x 1.2x
PSA Unlock Forecast - 30 Days FREE Trial $53082M 29.8x 5.7x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3946M 2.2x 0.4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3867M 2.1x 0.4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4272M 2.4x 0.5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3707M 2.1x 0.4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3522M 2.0x 0.4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3554M 2.0x 0.4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3436M 1.9x 0.4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3086M 1.7x 0.3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2892M 1.6x 0.3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2890M 1.6x 0.3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $3023M 1.7x 0.3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2971M 1.6x 0.3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2973M 1.6x 0.3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3086M 1.7x 0.3x
PW Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
PW-PA Unlock Forecast - 30 Days FREE Trial $89M x 15.1x
RC Unlock Forecast - 30 Days FREE Trial $511M -13.0x 0.3x
RCB Unlock Forecast - 30 Days FREE Trial $4028M -44.3x 2.2x
RCC Unlock Forecast - 30 Days FREE Trial $4054M -45.2x 2.2x
RCD Unlock Forecast - 30 Days FREE Trial $3987M x 2.2x
RC-PC Unlock Forecast - 30 Days FREE Trial $2610M x 1.4x
RC-PE Unlock Forecast - 30 Days FREE Trial $2483M x 1.4x
REG Unlock Forecast - 30 Days FREE Trial $13188M 61.0x 2.0x
REXR Unlock Forecast - 30 Days FREE Trial $9825M 29.0x 1.1x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5420M 17.1x 0.6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5203M 15.3x 0.6x
RHP Unlock Forecast - 30 Days FREE Trial $5627M 21.0x 7.0x
RITM Unlock Forecast - 30 Days FREE Trial $5785M 7.2x 0.7x
RITM-PA Unlock Forecast - 30 Days FREE Trial $13581M 16.9x 1.7x
RITM-PB Unlock Forecast - 30 Days FREE Trial $13517M 16.8x 1.7x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13194M 16.4x 1.7x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13072M 16.3x 1.7x
RLJ Unlock Forecast - 30 Days FREE Trial $1054M 18.2x 0.5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3802M 65.8x 1.7x
RPT Unlock Forecast - 30 Days FREE Trial $112M -0.8x 0.4x
SAFE Unlock Forecast - 30 Days FREE Trial $1129M 11.0x 0.5x
SBAC Unlock Forecast - 30 Days FREE Trial $21356M 24.0x -5.1x
SBRA Unlock Forecast - 30 Days FREE Trial $4335M 23.8x 1.6x
SELF Unlock Forecast - 30 Days FREE Trial $57M 22.8x 1.2x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10.5x 0.6x
SITC Unlock Forecast - 30 Days FREE Trial $464M 1.3x 1.0x
SKT Unlock Forecast - 30 Days FREE Trial $3771M 38.7x 5.9x
SLG Unlock Forecast - 30 Days FREE Trial $3683M -33.2x 1.0x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1541M x 0.4x
SMA Unlock Forecast - 30 Days FREE Trial $1176M x 1.0x
SPG Unlock Forecast - 30 Days FREE Trial $58375M 23.1x 23.8x
SQFT Unlock Forecast - 30 Days FREE Trial $50M 1.2x 1.4x
SQFTP Unlock Forecast - 30 Days FREE Trial $139M 24.7x 3.9x
STAG Unlock Forecast - 30 Days FREE Trial $7212M 30.9x 2.1x
STLY Unlock Forecast - 30 Days FREE Trial $24M 37.8x 0.6x
STRW Unlock Forecast - 30 Days FREE Trial $152M 25.5x 9.8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0.4x
STWD Unlock Forecast - 30 Days FREE Trial $6368M 17.2x 1.0x
SUI Unlock Forecast - 30 Days FREE Trial $15616M 12.2x 2.1x
SUNS Unlock Forecast - 30 Days FREE Trial $135M 13.4x 0.7x
SVC Unlock Forecast - 30 Days FREE Trial $395M -2.2x 0.6x
TCI Unlock Forecast - 30 Days FREE Trial $389M 58.9x 0.5x
TFSA Unlock Forecast - 30 Days FREE Trial $201M x 0.0x
TPTA Unlock Forecast - 30 Days FREE Trial $562M x 3.3x
TRTX Unlock Forecast - 30 Days FREE Trial $709M 10.6x 0.7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1390M 20.7x 1.3x
TWO Unlock Forecast - 30 Days FREE Trial $1016M -55.6x 0.4x
TWOD Unlock Forecast - 30 Days FREE Trial $2702M x 1.1x
TWO-PA Unlock Forecast - 30 Days FREE Trial $2437M x 1.0x
TWO-PB Unlock Forecast - 30 Days FREE Trial $2369M x 1.0x
TWO-PC Unlock Forecast - 30 Days FREE Trial $2469M x 1.0x
UDR Unlock Forecast - 30 Days FREE Trial $12006M 91.4x 3.6x
UHT Unlock Forecast - 30 Days FREE Trial $505M 28.2x 3.1x
UMH Unlock Forecast - 30 Days FREE Trial $1244M 40.8x 1.3x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63.1x 2.1x
VICI Unlock Forecast - 30 Days FREE Trial $32726M 12.1x 1.2x
VNO Unlock Forecast - 30 Days FREE Trial $7563M 8.6x 1.2x
VNO-PL Unlock Forecast - 30 Days FREE Trial $3466M 4.0x 0.6x
VNO-PM Unlock Forecast - 30 Days FREE Trial $3476M 4.0x 0.6x
VNO-PN Unlock Forecast - 30 Days FREE Trial $3491M 4.0x 0.6x
VNO-PO Unlock Forecast - 30 Days FREE Trial $2865M 3.3x 0.5x
VNORP Unlock Forecast - 30 Days FREE Trial $15661M 17.9x 2.6x
VRE Unlock Forecast - 30 Days FREE Trial $1407M 22.3x 1.2x
VTR Unlock Forecast - 30 Days FREE Trial $32502M 168.0x 2.8x
WELL Unlock Forecast - 30 Days FREE Trial $118937M 103.7x 3.3x
WHLR Unlock Forecast - 30 Days FREE Trial $4M 1.7x -0.7x
WHLRD Unlock Forecast - 30 Days FREE Trial $39M 17.5x -4.8x
WHLRL Unlock Forecast - 30 Days FREE Trial $126M 56.0x -21.2x
WHLRP Unlock Forecast - 30 Days FREE Trial $5M 2.0x -0.6x
WPC Unlock Forecast - 30 Days FREE Trial $14630M 44.1x 1.8x
WSR Unlock Forecast - 30 Days FREE Trial $622M 18.5x 1.5x
WY Unlock Forecast - 30 Days FREE Trial $17371M 62.3x 1.8x

Frequently Asked Questions - REGENCY CENTERS CORP Stock Forecast

How accurate are REGENCY CENTERS CORP stock predictions?

Our AI model shows a 59% Spearman correlation coefficient for REG predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence REGENCY CENTERS CORP stock price forecasts?

Our analysis considers REGENCY CENTERS CORP's financial metrics, Real Estate & Construction sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is REGENCY CENTERS CORP a good investment in 2025?

Based on our AI analysis, REGENCY CENTERS CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are REGENCY CENTERS CORP forecasts updated?

REGENCY CENTERS CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced REGENCY CENTERS CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for REGENCY CENTERS CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...